Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New hair loss pill enters final testing phase

NCT ID NCT07529977

First seen Apr 14, 2026 · Last updated Jun 15, 2026 · Updated 13 times

Summary

This study tests an oral medication called N1087 (minoxidil) to see if it can help regrow hair in men with male pattern baldness. About 372 men aged 18 to 60 with moderate hair loss will take either the drug or a placebo pill daily for 24 weeks. The main goal is to measure changes in hair density on the scalp using special photography.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANDROGENETIC ALOPECIA (AGA) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

alopecia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.